CUSIP: 33938JAB2
What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 33938JAB2:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q1 | $0 | $0 | -$85,041,966 | 0 | |
| 2021 Q4 | $68,506,000 | $71,019,966 | -$45,848,181 | 100.26% | 8 |
| 2021 Q3 | $143,488,000 | $130,126,940 | -$4,671,076 | 89.13% | 29 |
| 2021 Q2 | $148,558,940 | $136,555,335 | -$8,633,804 | 90.54% | 32 |
| 2021 Q1 | $165,016,982 | $150,165,234 | -$27,393,729 | 90.59% | 28 |
| 2020 Q4 | $193,457,850 | $178,112,225 | +$6,698,370 | 89.18% | 33 |
| 2020 Q3 | $200,698,000 | $158,456,645 | +$2,961,261 | 79.09% | 35 |
| 2020 Q2 | $185,674,000 | $158,958,846 | -$1,600,062 | 84.37% | 32 |
| 2020 Q1 | $185,789,000 | $148,356,905 | +$3,227,622 | 77.7% | 25 |
| 2019 Q4 | $179,075,271 | $191,174,159 | +$15,929,722 | 106.75% | 21 |
| 2019 Q3 | $167,897,000 | $151,735,244 | +$822,621 | 90.24% | 21 |
| 2019 Q2 | $167,336,758 | $146,294,481 | -$9,012,249 | 87.31% | 23 |
| 2019 Q1 | $177,668,000 | $155,068,000 | -$818,499 | 87.48% | 21 |
| 2018 Q4 | $178,325,000 | $146,577,000 | -$3,962,688 | 82.11% | 22 |
| 2018 Q3 | $180,626,000 | $183,142,000 | -$5,111,367 | 101.0% | 21 |
| 2018 Q2 | $183,854,000 | $225,108,000 | +$225,108,016 | 122.4% | 21 |